Full text is available at the source.
Abstract
Retatrutide (LY3437943) targets three key hormone receptors involved in metabolic health.
- It acts as a long-acting triple incretin receptor agonist.
- Its effects on body composition and metabolism may be significant.
- There are concerns about potential misuse in sports, particularly among physically active individuals.
- Current knowledge of its detection and elimination in humans is limited.
Simplified